Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - RESEARCH & DEVELOPMENT
Research & Development VIRX - Viracta Therapeutics, Inc.
33.4 M
LAST VALUE
18.26%
2 YEAR CAGR
17.95%
5 YEAR CAGR
1.45%
10 YEAR CAGR